This course examines the evolving landscape of pharmaceutical therapies for presbyopia, with a focus on emerging agents beyond pilocarpine. Attendees will explore novel mechanisms of action, investigational drugs in development, and the potential impact these therapies may have on presbyopia management. Emphasis will be placed on clinical trial data, patient selection considerations, and how these therapies may integrate into future optometric practice.